John S. Tokarski
37Patents
9h-index
116Co-inventors
78Inventor score
Filing activity: Oct 13, 2000 → Sep 5, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7723336B2 | Fused heterocyclic compounds useful as kinase modulators | Human Necessities | 42 | Active |
| US6653304B2 | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases | Chemistry; Metallurgy | 33 | Expired |
| US9273057B2 | Imidazotriazinecarbonitriles useful as kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9458156B2 | Tricyclic compounds as anticancer agents | Human Necessities | 22 | Active |
| US9505748B2 | Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses | Chemistry; Metallurgy | 15 | Active |
| US9663467B2 | Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses | Chemistry; Metallurgy | 13 | Active |
| US10000480B2 | Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses | Chemistry; Metallurgy | 13 | Active |
| US9315494B2 | Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses | Chemistry; Metallurgy | 12 | Active |
| US9540333B2 | Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα | Chemistry; Metallurgy | 10 | Active |
| USRE47929E1 | Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses | General | 9 | Active |
| US9987266B2 | Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses | Chemistry; Metallurgy | 6 | Active |
| US7547782B2 | Met kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7880004B2 | Met kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7084160B2 | Heterocyclic inhibitors of kinases | Chemistry; Metallurgy | 3 | Expired |
| US7141571B2 | Pyrrolotriazine compounds as kinase inhibitors | Human Necessities | 3 | Expired |
| US6795776B1 | Crystallographic structure of the androgen receptor ligand binding domain | Physics | 3 | Expired |
| US11021462B2 | Sulfone pyridine alkyl amide-substituted heteroaryl compounds | Chemistry; Metallurgy | 3 | Active |
| US10273237B2 | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses | Chemistry; Metallurgy | 3 | Active |
| US7297695B2 | Pyrrolotriazine compounds as kinase inhibitors | Human Necessities | 3 | Active |
| US9492460B2 | Carbazole compounds useful as bromodomain inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10053454B2 | Carbazole compounds useful as bromodomain inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10669272B2 | Substituted naphthyridinone compounds useful as T cell activators | Human Necessities | 2 | Active |
| US9751879B2 | Tricyclic compounds as anticancer agents | Human Necessities | 1 | Active |
| US7378426B2 | Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 | Chemistry; Metallurgy | 1 | Expired |
| US11787779B2 | Sulfone pyridine alkyl amide-substituted heteroaryl compounds | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.